Saad Yousef M E, Idris Hanan, Shugman Ibrahim M, Kadappu Krishna K, Rajaratnam Rohan, Thomas Liza, Mussap Christian, Leung Dominic Y C, Juergens Craig P, French John K
Department of Cardiology, Liverpool Hospital, Sydney, NSW, Australia; South Western Sydney Clinical School, the University of New South Wales, Sydney, NSW, Australia.
Department of Cardiology, Liverpool Hospital, Sydney, NSW, Australia; South Western Sydney Clinical School, the University of New South Wales, Sydney, NSW, Australia.
Heart Lung Circ. 2017 Jul;26(7):660-666. doi: 10.1016/j.hlc.2016.11.004. Epub 2016 Dec 9.
Detectable levels of high sensitivity (cardiac) troponin T (HsTnT), occur in the majority of patients with stable coronary heart disease (CHD), and often in 'healthy' individuals. Extreme physical activity may lead to marked elevations in creatine kinase MB and TnT levels. However, whether HsTnT elevations occur commonly after exercise stress testing (EST), and if so, whether this has clinical significance, needs clarification.
To determine whether HsTnT levels become elevated after EST (Bruce protocol) to ≥95% of predicted maximum heart rate in presumed healthy subjects without overt CHD, we assayed HsTnT levels for ∼5h post-EST in 105 subjects (median age 37 years).
Pre-EST HsTnT levels <5 ng/L were present in 31/32 (97%) of females and 52/74 (70%) of males. Post-EST, 13 (12%) subjects developed HsTnT levels >14 ng/L, with troponin elevation occurring at least three hours post-EST. Additionally, a detectable ≥ 50% increase in HsTnT levels (4.9→9ng/L) occurred in 28 (27%) of subjects who during EST achieved ≥ 95% of their predicted target heart rate. The median age of the subjects with HsTnT elevations to > 14ng/L post-EST was higher than those without such elevation (42 and 36 years respectively; p=0.038). At a median follow-up of 13 months no adverse events were recorded.
The current study demonstrates that detectable elevations occur in HsTnT post-EST in 'healthy' subjects without overt CHD. Future studies should evaluate the clinical significance of detectable elevations in post-EST HsTnT with long-term follow-up for adverse cardiac events.
在大多数稳定型冠心病(CHD)患者中可检测到高敏(心脏)肌钙蛋白T(HsTnT)水平,并且在“健康”个体中也常常出现。剧烈的体力活动可能导致肌酸激酶MB和肌钙蛋白T水平显著升高。然而,运动负荷试验(EST)后HsTnT水平是否普遍升高,如果是,这是否具有临床意义,尚需阐明。
为了确定在无明显CHD的假定健康受试者中,进行EST(布鲁斯方案)至预测最大心率的≥95%后HsTnT水平是否升高,我们在105名受试者(中位年龄37岁)EST后约5小时检测了HsTnT水平。
EST前,31/32(97%)的女性和52/74(70%)的男性HsTnT水平<5 ng/L。EST后,13名(12%)受试者的HsTnT水平>14 ng/L,肌钙蛋白升高发生在EST后至少三小时。此外,在EST期间达到预测目标心率≥95%的28名(27%)受试者中,HsTnT水平出现了可检测到的≥50%的升高(4.9→9 ng/L)。EST后HsTnT升高至>14 ng/L的受试者的中位年龄高于未升高者(分别为42岁和36岁;p = 0.038)。中位随访13个月时未记录到不良事件。
本研究表明,在无明显CHD的“健康”受试者中,EST后HsTnT出现可检测到的升高。未来的研究应通过对不良心脏事件的长期随访来评估EST后可检测到的HsTnT升高的临床意义。